about
Consolidation of proteomics data in the Cancer Proteomics database.Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.Cancer stratification by molecular imaging.Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer.Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications.Is phosphoproteomics ready for clinical research?Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometryDiagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryA Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Free-flow electrophoresis in proteome sample preparation.MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.Cancer proteomics: developments in technology, clinical use and commercialization.Proteome Analyses of Hepatocellular Carcinoma.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.Reversible protein affinity-labelling using bromomaleimide-based reagents.Differentially expressed and survival-related proteins of lung adenocarcinoma with bone metastasis.
P2860
Q30990489-33ED634D-AC86-4E1C-B3FC-2ECD52829C4AQ33946598-7EB92FB6-9A58-46EC-9820-66D4C36D992CQ34350615-12150EA8-0DB8-409C-A3E0-DE03BC010048Q34768509-8C6EF59C-BA9F-4492-B030-DA490C9F5524Q35380664-5647997E-21AF-4A95-AD30-6A960648F22FQ35607101-F09677AE-72DA-40FA-BF57-21EA23BB05BEQ36640672-54E894EA-FA5E-4172-A8F7-4D17587E7812Q36799469-58540854-9842-4809-8BEC-AE98ECBB9FCFQ37174708-8A82BCA1-AA11-4F00-9BE4-9DDE90AEAAC0Q37187745-440B433B-28FB-46A4-B480-E2EC8976AB69Q37651691-7A3EAFF1-2DB8-4990-9FAC-91B9ACDD7DEAQ38152407-9EB1AF27-5E3C-40F5-B050-E647F0E60C4EQ38183147-BA9BDCD3-4EB3-4E05-BB7A-D2F42B8E9849Q38203040-F6C5F69C-C46D-4D93-8ED1-C9A6A5D6ED8EQ38215756-068B018A-7FA5-4876-9417-01EA2B685510Q38543009-D6E2D42E-C6A7-447C-B05E-DAD26EAAF719Q38584282-225D0FEE-78FC-49A4-8708-8B50B6A52987Q38753775-EECA7A3D-AC76-47B9-9176-88BE04925099Q38981242-08E3F810-E7FB-4A15-BEC1-B225727092FBQ39021766-76C1E76C-2AAD-4FFB-B8AA-AC70675B2E5FQ42585959-1060329D-C9CD-4074-852F-0F5D2579620DQ54122218-05840FF7-330E-4222-9701-3F21DE9E94E9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cancer proteomics.
@en
Cancer proteomics.
@nl
type
label
Cancer proteomics.
@en
Cancer proteomics.
@nl
prefLabel
Cancer proteomics.
@en
Cancer proteomics.
@nl
P2093
P2860
P356
P1476
Cancer proteomics.
@en
P2093
Hwee Tong Tan
Maxey C M Chung
Yie Hou Lee
P2860
P304
P356
10.1002/MAS.20356
P577
2012-03-15T00:00:00Z